Real-world treatment landscape in advanced metastatic castration resistant prostate cancer

被引：0
|
作者：
Sacchi, Elizabeth
Singhal, Hari
Zamalloa, Jose
Sanchez, Beatriz Lopez
Zhang, Ke
Parihar, Harish
Greshock, Joel
Max, Steven I.
机构：
[1] Johnson & Johnson Innovat Med, Cambridge, MA USA
[2] Janssen Res & Dev, San Francisco, CA USA
[3] Johnson & Johnson Innovat Med, Lawrence, NJ USA
[4] Johnson & Johnson Innovat Med, Leiden, Netherlands
[5] Janssen Res & Dev La Jolla, San Diego, CA USA
[6] Janssen Pharmaceut, Clovis, CA USA
[7] Johnson & Johnson Innovat Med, Res & Dev, Raritan, NJ USA
[8] Janssen Pharmaceut Inc, Spring House, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17032
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-world treatment patterns among patients with metastatic castration-resistant prostate cancer (mCRPC) in the US.
    Malangone-Monaco, Elisabetta
    Li, Weiyan
    Noxon, Virginia
    Jiang, Shan
    Amin, Suvina
    Ghate, Sameer
    Swami, Umang
    Agarwali, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [22] Efficacy of Novel Hormone Agents in the Treatment of Metastatic Castration-resistant Prostate Cancer: A Real-world Retrospective Study
    LI, Jian-ri
    Wang, Shian-shiang
    Chen, Chuan-shu
    Yang, Cheng-kuang
    Lu, K. E. V. I. N.
    Cheng, Chen-Li
    Hung, Sheng-Chun
    Chen, Shu-Yen
    Hsu, Chiann Yi
    Chiu, Kun-Yuan
    ANTICANCER RESEARCH, 2022, 42 (10) : 4857 - 4866
  • [23] REAL-WORLD EFFECTIVENESS AND TREATMENT ADHERENCE OF APALUTAMIDE IN NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS
    Lowentritt, Benjamin
    Brown, Gordon
    Kernen, Kenneth
    Pilon, Dominic
    Ellis, Lorie
    Germain, Guillaume
    Rossi, Carmine
    Lefebvre, Patrick
    Sieber, Paul
    Shore, Neal
    JOURNAL OF UROLOGY, 2021, 206 : E58 - E58
  • [24] Real-world outcomes in second-line treatment of metastatic castration-resistant prostate cancer (mCRPC): The Prostate Cancer Registry.
    Chowdhury, Simon
    Birtle, Alison J.
    Bjartell, Anders
    Costa, Luis
    Feyerabend, Susan
    Galli, Luca
    Kalinka-Warzocha, Ewa
    Kramer, Gero
    Lumen, Nicolaas
    Maroto, Pablo
    Matveev, Vsevolod B.
    Paiss, Thomas
    Pisconti, Salvatore
    Spaeth, Dominique
    Veiga, Francisco Gomez
    Antoni, Laurent
    Klumper, Edwin
    Wapenaar, Robert
    van den Berg, Erik
    Lee, Emma
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [25] Real-world outcomes in first-line treatment of metastatic castration-resistant prostate cancer (mCRPC): The prostate cancer registry.
    Chowdhury, Simon
    Birtle, Alison J.
    Bjartell, Anders
    Costa, Luis
    Feyerabend, Susan
    Galli, Luca
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [26] Abiraterone acetate in metastatic castration-resistant prostate cancer – the unanticipated real-world clinical experience
    Darren M. C. Poon
    Kuen Chan
    S. H. Lee
    T. W. Chan
    Henry Sze
    Eric K. C. Lee
    Daisy Lam
    Michelle F. T. Chan
    BMC Urology, 16
  • [27] Efficacy of abiraterone acetate in castration-resistant metastatic prostate cancer: A real-world data analysis
    Oyman, Abdilkerim
    Basak, Mustafa
    Ozcelik, Melike
    Ozyukseler, Deniz Tataroglu
    Isik, Selver
    Yildirim, Mahmut Emre
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (05) : E201 - E207
  • [28] Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in Canada
    Shayegan, Bobby
    Wallis, Christopher J. D.
    Malone, Shawn
    Cagiannos, Ilias
    Hamilton, Robert J.
    Ferrario, Cristano
    Gotto, Geoffrey T.
    Basappa, Naveen S.
    Morgan, Scott C.
    Fernandes, Ricardo
    Morash, Christopher
    Niazi, Tamim
    Noonan, Krista L.
    Rendon, Ricardo
    Osborne, Brendan
    Park-Wyllie, Laura
    Chan, Katherine F. Y.
    Hotte, Sebastien J.
    Saad, Fred
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (05) : 192.e1 - 192.e9
  • [29] STATINS AND ORAL TREATMENTS IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC): REAL-WORLD OUTCOMES
    Engel-Nitz, Nicole
    Behl, Ajay
    Blauer-Peterson, Cori
    Dawson, Nancy
    JOURNAL OF UROLOGY, 2017, 197 (04): : E675 - E675
  • [30] Abiraterone acetate in metastatic castration-resistant prostate cancer - the unanticipated real-world clinical experience
    Poon, Darren M. C.
    Chan, Kuen
    Lee, S. H.
    Chan, T. W.
    Sze, Henry
    Lee, Eric K. C.
    Lam, Daisy
    Chan, Michelle F. T.
    BMC UROLOGY, 2016, 16
12345